Cleared Traditional

K183560 - Luna 3D GEN2 Interbody Fusion System

K183560 is the FDA 510(k) clearance for Luna 3D GEN2 Interbody Fusion System by Benvenue Medical, Inc.. It is a Class 2 Orthopedic device (product code MAX) cleared through the Traditional 510(k) pathway after a 154-day FDA review.

K183560 · Benvenue Medical, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2019
Decision
154d
Days
Class 2
Risk

K183560 is an FDA 510(k) clearance for the Luna 3D GEN2 Interbody Fusion System. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Benvenue Medical, Inc. (Santa Clara, US). The FDA issued a Cleared decision on May 23, 2019 after a review of 154 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Benvenue Medical, Inc. devices

Submission Details

510(k) Number K183560 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2018
Decision Date May 23, 2019
Days to Decision 154 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 122d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Musculoskeletal Clinical Regulatory Advisers, LLC
Justin Eggleton

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 595
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K183560.
TxTi IBF System
K183064 · Innovasis, Inc. · Jun 2019
LxHA PEEK Lateral IBF System
K190684 · Innovasis, Inc. · Jun 2019
ProLift® Expandable System
K191005 · Life Spine, Inc. · Jun 2019
UNiD Patient specific 3D printed TLIF cage
K190092 · Medicrea International SA · May 2019
Capstone Control™ Spinal System
K190165 · Medtronic Sofamor Danek USA, Inc. · May 2019
HALF DOME Posterior Lumbar Interbody System
K182877 · Astura Medical, LLC · May 2019